Evidence map›Paper›PMID 33359539›Full record

Observational studyClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator.

Cristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, Marianna Meschiari, Erica Franceschini, Carlotta Rogati, Gianluca Cuomo, Andrea Bedini, Vittorio Iadisernia, Sara Volpi and 10 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. [Effect of rehabilitation on functionality/quality of life in stroke due to COVID-19].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Observational
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sex-biased clinical presentation and outcomes from COVID-19.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Cristina MussiniDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy. Electronic address: cristina.mussini@unimore.it.
Alessandro Cozzi-LepriCentre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK.
Marianna MenozziDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Marianna MeschiariDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Erica FranceschiniDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Carlotta RogatiDepartment of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
Gianluca CuomoDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Andrea BediniDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Vittorio IadiserniaDepartment of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
Sara VolpiDepartment of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
Jovana MilicDepartment of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
Roberto TonelliClinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy; Respiratory Diseases Unit, Azienda Ospedaliero-Universitaria Policlinic o of Modena, Modena, Italy.
Lucio BrugioniInternal Medicine Department, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Antonello PietrangeloDepartment of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Italy.
Massimo GirardisDepartment of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy; Department of Anaesthesia and Intensive Care Unit, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Andrea CossarizzaDepartment of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Italy.
Enrico CliniRespiratory Diseases Unit, Azienda Ospedaliero-Universitaria Policlinic o of Modena, Modena, Italy; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Italy.
Giovanni GuaraldiDepartment of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
Modena Covid-19 Working Group (MoCo19)
Office of information and communication technologies of Policlinico di Modena
Azienda Ospedaliero-Universitaria di Modena · ITUniversity of Modena and Reggio Emilia · ITNational Institute for Health Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSex differences in COVID-19 severity and mortality have been described. Key aims of this analysis were to compare the risk of invasive mechanical ventilation (IMV) and mortality by sex and to explore whether variation in specific biomarkers could mediate this difference.

methodsThis was a retrospective, observational cohort study among patients with severe COVID-19 pneumonia. A survival analysis was conducted to compare time to the composite endpoint of IMV or death according to sex. Interaction was formally tested to compare the risk difference by sex in sub-populations. Mediation analysis with a binary endpoint IMV or death (yes/no) by day 28 of follow-up for a number of inflammation/coagulation biomarkers in the context of counterfactual prediction was also conducted.

resultsAmong 415 patients, 134 were females (32%) and 281 males (67%), median age 66 years (IQR 54-77). At admission, females showed a significantly less severe clinical and respiratory profiles with a higher PaO DISCUSSION: Our analysis confirms a difference in the risk of COVID-19 clinical progression by sex and provides a hypothesis for potential mechanisms leading to this. Specifically, CRP showed a predominant role to mediate the difference in risk by sex.

Indexed as

AgedCohort StudiesCOVID-19FemaleHospitalizationHumansInflammationMaleMiddle AgedPrognosisRespiration, ArtificialRetrospective StudiesRisk FactorsSARS-CoV-2Sex FactorsCOVID-19COVID-19 pneumoniaInflammationMediationPrognosisSex differences

Identifiers

PMID33359539
PMCPMC7816626
OpenAlexW3115351179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.